Wiley Launches New Open Access Journal: Immunity, Inflammation and Disease
Immunity, Inflammation and Disease, the latest journal to be launched from the Wiley Open Access program, is supported by a number of major societies; British Society for Immunology; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology; and the British Society for Allergy and Clinical Immunology, as well as leading journals in the field, including Allergy (Impact Factor 6.3), European Journal of Immunology (Impact Factor 5.1) and Clinical and Experimental Allergy (Impact Factor 5.0).
All articles in Immunity, Inflammation and Disease will be published open access under the Creative Commons Attribution (CC-BY) License on Wiley Online Library and deposited in PubMed Central immediately upon publication. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organization that has a Wiley Open Access Account can publish without directly paying any publication charges.
Marc Veldhoen, a group leader at the Babraham Institute in Cambridgeshire, UK, has been appointed as Editor-in-Chief for the new journal. Dr. Veldhoen studied Medical Biology at the Faculty of Medicine, Utrecht University, The Netherlands and went on to pursue his post doctorate at the National Institute for Medical Research Mill Hill, UK.
“It is my hope and goal with Immunity, Inflammation and Disease to make a contribution towards quality open access scientific publishing and to stimulate debate. Being part of Wiley means we will make full use of its experience with quality peer reviewed scientific publishing,” said Dr. Veldhoen. “My aims are to shape it into a high quality journal publishing new and original data, and to encourage the preservation of the original scientific method of open discussion and frank exchange of thoughts and ideas.”
“We are delighted to be launching this new open access journal in immunology, particularly with support of our long term publishing partners which will be invaluable in ensuring that the new journal goes from strength to strength,” said Bob Campbell, Senior Publisher, Wiley.
The journal is open to submissions now. Visit the journal’s website www.immunityinflammationdisease.com for further information and future updates.